<DOC>
	<DOC>NCT01955343</DOC>
	<brief_summary>This study is designed to evaluate the importance of the immune cells localization (distribution) between malignant tumor islets and surrounding stroma and to investigate the associations between these immune cells as well as cytokines and clinicopathological and prognostic factors of non-small cell lung cancer (NSCLC) patients.</brief_summary>
	<brief_title>Immune Response in Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Eastern Cooperative Oncology Group (ECOG) score of 01 Patients with histologically documented nonsmall cell lung cancer Control group patients without nonsmall cell lung cancer Written (signed) Informed Consent to participate in the study Any other malignancies within 5 years Any unstable systemic disease (including active infections, significant cardiovascular disease) Prior chemotherapy or radiotherapy Autoimmune disease Nursing or pregnant women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Immune response</keyword>
	<keyword>Cancer</keyword>
</DOC>